Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag

Overdiagnosis and overtreatment of prostate cancer (CaP) is attributable to widespread reliance on PSA screening in the US. This has prompted us and others to search for improved biomarkers for CaP, to facilitate early detection and disease stratification. In this regard, autoantibodies (AAbs) again...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastogi, Anshu, Ali, Amina, Tan, Shyh-Han, Banerjee, Sreedatta, Chen, Yongmei, Cullen, Jennifer, Xavier, Charles P., Mohamed, Ahmed A., Ravindranath, Lakshmi, Srivastav, Jigisha, Young, Denise, Sesterhenn, Isabell A., Kagan, Jacob, Srivastava, Sudhir, McLeod, David G., Rosner, Inger L., Petrovics, Gyorgy, Dobi, Albert, Srivastava, Shiv, Srinivasan, Alagarsamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302040/
https://www.ncbi.nlm.nih.gov/pubmed/28191285
http://dx.doi.org/10.18632/genesandcancer.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302040/
https://www.ncbi.nlm.nih.gov/pubmed/28191285
http://dx.doi.org/10.18632/genesandcancer.126

Ejemplares similares